BVI, WV
Terms
undefined, object
copy deck
- define adjuvant therapy and give an example of its use
- treatment given to eradicate microscopic amounts of cancer that may remain after removal of a solid tumor (ie. breast CA)
- define induction therapy and give an example of its use
- treatment to induce remission for a cancer treated primarily with chemotherapy (ie. leukemia, lymphoma)
- define consolidation therapy and give an example of its use
- treatment given after induction therapy intended to produce sustained remission
- define neoadjuvant therapy and give an example of its use
- treatment used to shrink a tumor before it is removed or irradiated (ie. shrink a breast cancer to make it more easily resected)
- define palliative therapy and give an example of its use
- treatment given to attempt to shrink or stabilize an incurable cancer (most common usage of chemo). (ie. CLL or Multiple Myeloma)
- define direct local therapy and give an example of its use
- treatment given directly into an organ or cavity to deliver higher doses to a specific area (area may be protected from toxic substances - ie. CNS and BBB)(another example is liver)
- describe the phases of drug testing
-
phase I - dose finding
phase II - looking for efficacy
phase III - compare to Gold Standard
phase IV - generic testing - MOA of Alkylating Agents?
-
impair cell function by forming covalent bonds with biologically important molecules (ie. DNA, RNA, proteins)
*dependant on cell proliferation for activity* - MOA of antimetabolites?
-
compete with normal metabolites for the catalytic or regulatory site of a key enzyme or by substituting fofr a metabolite that is normally incorporated into DNA or RNA
*works best in S phase* -
describe the dose response curve for antimetabolites
- what does this mean? -
non-linear dose response curve
(beyond a certain dose no more cells are killed despite a higher dose of drug) -
MOA of folate analog?
name of folate analog drug? -
prevents the reduction of folic acid to tetrahydrofolic acid by binding reversibly to dihydrofolate reductase
(methotrexate is prototype) - reversal agent for methotrexate (folate analog)?
- folininic acid
- when are folate analogs (methotrexate) used? (2)
-
lymphomas
sarcomas - MOA of purine analogs?
- block purine/DNA synthesis by inhibiting ribonucleotide reductase
- Purine analogs are used in which two disorders??
-
CLL
Low grade lymphomas - MOA of pyrimidine analogs?
- inhibits DNA polymerase - this is incorporated into DNA and causes strand breaks
- Pyrimidine analogs are used to treat? (3)
-
AML
Lymphoma
MDS - prototype pyrimidine analog?
- cytarabine
- MOA of adenosine analogs?
- adenosine analog is resistant to metabolic inactivation by the enzyme adenosine deaminase. analog is incorporated into DNA causing strand breaks
- adenosine analogs are used to treat? (3)
-
Hairy cell leukemia
Waldenstrom's
CLL - MOA of substituted urea (hydroxyurea)?
- blocks DNA by inhibiting ribonucleotide reductase
- substituted urea (hydroxyurea) is used to treat? (4)
-
*chronic myeloproliferative disorders*
- CML
-P.vera
-E.T.
- reduction of blasts in AML - General toxicities of antimetabolite therapy?
-
1. GI
2. Marrow suppression
3. Neurotoxicity
4. Acute MI (5-FU)
5. nausea (mild xcept MTX) - MOA of anthracyclines (antitumor antibiotic)
-
DNA intercalators insert between DNA base pairs - creates breaks in DNA strands.
- also interferes with topoisomerases (prevents re-litigation of strands during DNA replication) - toxicities of anthracyclines? (3)
-
1. alopecia
2. cardiotoxic
3. chemical vessicants (tissue burns) - MOA of Bleomycin?
- intercalates DNA at G-C and G-T sequences - causes free oxygen radicals that go on to cause strand breakage
- Bleomycin is used to treat? (3)
-
1. Hodgkin's
2. testicular cancer
3. lymphomas - Toxicities of bleomycin? (4)
-
1. pulmonary fibrosis (O2 administration exascerbates)
2. flu-like rxn
3. anaphylaxis
4. hyperpigmentation - MOA of vinca alkaloids?
- M-phase specific alkaloids that bind to tubulin so that microtubules cannot polymerize. this impairs mitotic spindle formation
- toxicities of vinica alkaloids? (3)
-
1. neurotoxicity
2. ileus
3. marrow suppression - MOA of taxanes
- promote assembly and stabilization of microtubules
- what are the two classes of antimicrotubule agents?
-
1. Vinca Alkaloids
2. Taxanes - what are the two classes of antitumor antibiotics?
-
1. Anthracyclines
2. Bleomycin - MOA of steroids as chemotherapy?
- directly toxic to lymphocytes and malignant lymphoid cells. thought to trigger apoptosis
- steroids use to treat which malignancies? (4)
-
1. CLL
2. ALL
3. Myeloma
4. Lymphoma - MOA of platinum compounds?
-
(technically considered alkylating agents)
produce DNA crosslinks which inhibit the synthesis of DNA, RNA and protien. - platinum compounds used to treat? (2)
-
1. many solid tumors (lung, breast, testicular)
2. refractory lymphomas, acute leukemias - toxicities of platinum compounds? (3)
-
1. nephrotoxic
2. vomiting
3. myelosuppression - MOA of L-Asparaginase?
- depletes tumor cells of asparagine (an AA needed for protein synthesis). normal cells can synthesize asp intracellularly and are therefore spared the toxicity.
- L-Asparaginase is used to treat? (1)
- ALL
- toxicities of L-Asparaginase? (2)
-
1. hypersensitivity
2. pancreatitis - MOA of Rituxumab?
- anti-CD20 monoclonal antibody that binds compliment - causes compliment and Ab dependant cellular cytotoxicity by directly inducing apoptosis
- rituxumab used to treat?
-
multiple B cell malignancies
- must be CD20 positive -
1. the body normall produces IFN-alpha in response to?
2. what cells produce it? -
1. viral infections
2. lymphocytes - MOA of recombinant IFN-alpha used for chemotherapy?
-
direct anti-viral activity.
- increases expression of MHC and tumor associated antigens.
- also increases NK function - IFN-alpha is used to treat which cancers? (4)
-
1. chronic phase CML
2. maintain remission in myeloma
3. kidney cancer
4. melanoma - MOA of Imatinib mesylate (Gleevec)?
-
Tyrosine kinase inhibitor
- Bcr-Abl fusion protein acts as a tyrosine kinase which transforms normal cells to malignant ones. Imatinib stops this by inhibiting this specific tyrosine kinase. - Imatinib is used to treat? (3)
-
1. chronic and accelerated phases of CML
2. GI stromal tumors
3. Ph positive ALL - MOA of thalidomide?
- anti-angiogenesis factor
- thalidomide is used to treat? (2)
-
1. myeloproliferative disorders
2. myeloma - MOA of Bortezomib?
-
26S Proteosome inhibitor
- prevents proteolysis
- disrupts signal cascades within cell - Bortezomib is the 2nd line treatment for?
- Myeloma
- MOA of All-Trans Retinoic Acid?
- induces maturation in APL cells (t15;17)
- toxicities of All-Trans Retinoic acid? (2)
-
1. RA-APL Syndrome (25%)
- fever, dyspnea, wt. gain, lung infiltrates
2. leukocytosis (40%) - what is the treatment for RA-APL syndrome?
- steroids
- what is Neupogen and what is it used for? (4)
-
Neupogen is G-CSF: a recombinant DNA product which contains the G-CSF gene
It is used to:
1. treat chemo induced
myelosuppression
2. supplement BMT
3. assist with stem cell collection
4. treat chronic neutropenia - what is the name for the recombinant GM-CSF and what is it used for?
-
Leukine
used for AML and allo or auto transplants - What is Neumega and what is it used for?
-
Megakaryocyte stimulating factor (IL-11)
used to treat post-chemotherapy thrombocytopenia -
Cyclophosphamide:
What type of drug is it and what is it used to treat? (4) -
Alkylator
used to treat:
- lymphoma
- breast CA
- CLL
- Lymphoblastic anemia -
Nitrogen Mustard:
1. What type of drug is it and
2. what is it used to treat? -
1. Alkylator
2. Hodgkins lymphoma -
Azacitadine:
1. What type of drug is it and
2. what is it used to treat? (2) -
1. antimetabolite
2. MDS, AML -
Chlorambucil:
1. What type of drug is it and
2. what is it used to treat? -
1. alkylator
2. CLL -
Mephalan:
1. What type of drug is it and
2. what is it used to treat? -
1. alkylator
2. multiple myeloma -
Epirubicin:
1. What type of drug is it and
2. what is it used to treat? (3) -
1. antitumor antibiotic
2. breast, AML, esophagus -
Capecitabine:
1. What type of drug is it and
2. what is it used to treat? (2) -
1. antimetabolite (pyrimidine analog)
2. breast and colon CA -
Doxorubicin:
1. What type of drug is it and
2. what is it used to treat? (4) (2) -
1. antitumor antibiotic
2. breast, lymphomas, Hodgkin's, bladder -
Gemcitabine:
1. What type of drug is it and
2. what is it used to treat? (3) -
1. antimetabolite (pyrimidine analog)
2. pancreas, breast, other GI -
Ifosfamide:
1. What type of drug is it and
2. what is it used to treat? -
1. alkylator
2. sarcoma, testicular cancers -
Danorubicin and Idarubicin:
1. What type of drug is it and
2. what is it used to treat? -
1. antitumor antibiotics
2. AML -
Mitoxantrone:
1. What type of drug is it and
2. what is it used to treat? (4) -
1. antitumor antibiotic
2. AML, ALL, prostate, lymphomas -
5-FU:
1. What type of drug is it and
2. what is it used to treat? (3) -
1. antimetabolite (pyrimidine analog)
2. colon, breast, other GI CAs -
Vincristine, Vinblastine, Vinorelbine:
1. What type of drug is it and
2. what is it used to treat? (5) -
1. Vinca Alkaloids
2. lymphomas, ALL, myeloma, Hodgkin's, other tumors (breast, lung, kidney) - what must developing blood cells "undergo" before they are able to leave the bone marrow?
- they must maneuver through the sinusoids
- describe the fat content in the bone marrow in a young person vs. an old person?
-
as a person ages, fat in the bone marrow increases
rule: 100-age= % cellularity) - what is the function of adventitial reticular cells?
-
promote hemostasis of the bone marrow and line the sinusoids
they determine whether developing blood cells function and can leave the bone marrow. - where are most bone biopsies taken?
- posterior iliac crest
- what are the four hematopoietic stem cells?
-
1. pluripotent
2. multipotent (comitted to either myeloid or lymphoid lineages)
3. progenitor
4. precursor cells ("blasts") -
if the % neutrophils is 50%,
what is the absolute neutrophil count? -
5,000
(.5 x 10,000)
10,000 is normal WBC count - which type of infections are characteristic of agranulocytosis?
-
ulcerating necrotizing infections
(bacterial or fungal) - three morphologic changes seen in neutrophilia?
-
1. Dohle bodies
2. toxic granulation
3. cytoplasmic granules - why are toxic granulations formed?
- cells are released before they are completely mature
- why are cytoplasmic vacuoles and Dohle bodies seen in neutrophilia?
- characteristic of reactive changes
-
Dr. Raymond guaranteed Q:
very large lymphocytes seen in lymphocytosis of a young female would very likely be? - Infectious mononucleosis
- three major causes of eosinophilia?
-
1. parasites
2. allergic disorders (MCC)
3. skin disorders - where in the lymph node are B cells found?
- in the follicles of the cortex
- where in the lymph node are T cells found?
- paracortex
- what normally passes through the capsule of the lymph node?
- afferent and efferent lymph
-
these 3 disorders are commonly associated with which type of reactive lymph node disorder?
1.prominent germinal centers
2. variation in size and shape of follicles
3. associated with RA, toxoplasmosis, early HIV - Follicular hyperplasia
- what three clues upon lymph node examination help us to differentiate lymphadenitis from lymphadenomas?
-
non-malignant lymph nodes are:
1. tender
2. enlarged
3. mobile
in a malignancy they are nontender and nonmobile - what is the most common cause of sinus histiocytosis thought to be?
- thought to be an immune response against a tumor (seen alot in response to breast cancer)
- in which type of hyperlasia do T cells undergo transformation to immunoblasts?
- paracortical lymphoid hyperplasia
- the majority of non-Hodgkins lymphomas (80-85%) are of which origin?
- B-cell origin
- what is notable about the type of proliferation seen in NHL?
- monoclonal proliferation
- when in life do most B cell NHLs appear?
- 6th or 7th decade
- which two lymphomas are the only ones common in children?
-
1. Burkitt
2. Large B-cell lymphoma -
in NHL:
2/3 present with non-tender nodal enlargement
1/3 present with extranodal involvement.
where are these extranodal tissues? -
oropharynx
gut
skin
brain - what is the difference in prognosis between an indolent and an agressive lymphoma.
-
indolent: slow course, generally incurable
aggressive: rapid progression, may be curable - what are two examples of indolent lymphomas?
-
CLL
follicular lymphoma - what are two examples of aggressive lymphomas?
-
Burkitt
Large B cell - what are the three classifications that WHO uses for lymphomas?
-
1. lymphomas with predominant lymphadenopathy
2. lymphomas with predominant extranodal involvement
3. lymphomas with predominant bone marrow involvement - which type of lymphoma is the most common form of NHL in adults?
- follicular lymphomas
- describe the morphology/growth pattern seen in follicular lymphoma
-
nodular growth pattern
no capsules - describe the genetic alterations seen in follicular lymphoma
-
(14,18) translocation
result is overexpression of BCL-2 protein
BCL-2 is an antagonist of apoptosis - describe the B cell origin seen in follicular lymphoma
-
CD19+
CD20+
CD10+
(positive for B cell markers)
CD5- - exactly which loci are translocated in follicular lymphoma?
-
heavy chain (IgH) locus on chromosome 14
BCL-2 locus on chromosome 18 - function of BCL-6?
-
regulates germinal center development
(seen in follicular lymphoma) - in 30-50% of cases, follicular lymphoma transforms to which 2 lymphomas?
-
1. diffuse large cell lymphoma
2. Burkitt-like lymphoma - median survival of follicular lymphoma?
-
7-9 years
(indolent but not curable) - what is the second most common B cell lymphoma?
- Diffuse Large B-cell lymphoma
- most common age of diffuse B-cell lymphoma?
-
middle age or elderly
(also seen in 5% of childhood lymphomas) - genetics of diffuse B-cell lymphomas show which translocation? (3)
-
BCL6 translocation
(14,18) translocation in 10%
mutations in c-myc oncogene - two subtypes of diffuse large cell B-lymphomas?
-
1. immundoeficiency associated large B-cell lymphomas
2. Body cavity large cell lymphoma - how does Diffuse Large B-cell lymphoma present?
- rapidly enlarging mass at a single nodal or extranodal site
- what are the three types of Burkitt's lymphoma?
-
1. endemic in Africa
2. non-endemic in US
3. aggressive subset in HIV patients - describe the hallmark morphology seen in Burkitts
-
high mitotic index
benign macrophages create (STARRY SKY PATTERN) - describe B cell origin of Burkitts lymphoma
-
idicates origin from germinal centers
CD19+
CD20+
CD10+
BCL-6+ - which translocation is associated with Burkitts?
-
(8,14) translocation
c-MYC oncogene on chr. 8
heavy chain locus on chr. 14 - which virus are the majority of African cases associated with?
- EBV
-
regarding Burkits lymphoma:
describe the presentation in:
1. African (endemic)
2. US -
1. mandible
2. ileocecum, peritoneum - describe the progression of Burkitt's lymphoma
-
very aggressive
highly responsive to chemo
most children and young adults cured - what is the other name for Small lymphocytic lymphoma? (SLL)
-
chronic lymphocytic leukemia (CLL)
leukemic form of SLL - how common is CLL?
- extremely (25%)
- avg. age of CLL/SLL patient?
- >50 yrs
- describe the cell markers seen in CLL/SLL
-
CD19+
CD20+
also
CD23+
CD5+ - significance of CD5+?
-
T cell marker
this is used for diagnosis of CLL/SLL - MC chromosomal abnormality SOMETIMES seen in CLL/SLL?
- trisomy 12
- median survival of CLL pt?
- 4-6 yrs
-
guaranteed Q:
older adult male with pancytopenia, hypercellular bone marrow; and splenomegaly - what is it? - Hairy Cell Leukemia
- what are hairy cells and where are they found?
-
malignant B cells
ciculate in peripheral blood, bone marrow and spleen - which test, if positive, is a reliable indicator of hairy cell leukemia?
-
TRAP
(tartrate-resistant acid phosphatase) - current treatments for HCL?
-
interferons
chemotherapy
(lasting remission and possible cures) - why is a dry tap commonly seen in HCL?
- reticulin fibrosis of bone marrow
- what type of neoplasm is characterized by expansion of a single clone of Ig secreting cells?
- plasma cell neoplasm
- what are Bence-Jones proteins?
- light chains of Igs that are small enough to be excreted in the urine
- what happens to the heavy chains in a plasma cell neoplasm?
- they circulate in the plasma
- what is the most common plasma cell neoplasm?
- Multiple myeloma
- what is multiple myeloma characterized by?
- skeletal involvement at multiple sites
- which molecules actually mediate the bone destruction seen in MM?
- cytokines
- which two hallmark lab findings are seen in MM?
-
Roleaux formation
anemia - most myelomas are disorders of which Ig?
-
IgG
(then IgA) - why is there hypercalcemia seen in MM?
- from breakdown of bone in "punched out" bone lesions
- MCC of death in MM pts?
-
recurrent infections
(due to decrease in all other Ig's besides the one elevated) - renal involvement is multifactorial in MM. what are three causes?
-
1. Bence-Jones proteins
2. metastatic calcification (due to hypercalcemia)
3. amyloidosis - median survival of MM?
- 3 yrs
- two treatments for MM?
-
chemotherapy
bone marrow transplant - what is significant about solitary myeloma? (plasmacytoma)
- most bony lesions eventally progress to MM
- lymphoplasmacytic lymphoms (Waldenstrom's macroglobulinemia) is characterized by plasma cells that secrete?
- monoclonal IgM
- lymphoplasmacytic lymphoma (Waldenstrom's) is best viewed as a cross between?
- MM and SLL
- describe the morphology seen in lymphoplasmacytic lymphoma (waldenstroms)
-
Roleaux formation
lymphoplasmacytic lymphocytes - age of presentation of lymphoplasmacytic lymphoma?
- 6th-7th decade
- what are two hallmark problems seen in lymphoplasmacytic lymphoma?
-
1. bleeding (Igs form complexes with clotting factors)
2. hyperviscosity syndrome (due to large size of IgM) - what is the hallmark of monoclonal gammopathy of undetermined significance?
-
dysproteinemia without associated disease
(20% progress to MM, waldentrom's or amyloidosis) - what is the most common form of malignancy in young adults (10-30)?
- Hodgkin's Lymphoma
- what is the distinctive malignant cell seen in Hodgkin's lymphoma?
- Reed-Sternberg cell
- origin of R-S cell?
- germinal center derived B cells
- how do clinical features differ from NHL?
-
most often localized to a group of lymph nodes
(NHL - diffuse) - what are the 5 subtypes of HL?
-
1. nodular sclerosis (MC)
2. mixed cellularity
3. lymphocyte rich
4. lymphocyte depletion
5. lymphocyte predominant - describe how lymphocyte predominant HL presents
-
only type of HL that stains like a B cell lymphoma
CD45+, CD20+ (Bcell markers)
CD15-, CD30- (R-S markers) - CD staining in Nodular sclerosing HL?
-
CD15+, CD30+
CD45-, CD20- - which R-S variant is seen in nodular sclerosing
- lacunar cell
-
classic test scenario:
20 yr old female presents to clinician with fatigue
cervical, supraclavicular lymph nodes enlarged
multiple mediastinal lymph nodes on X-ray,
R-S cell -
nodular sclerosing HL
(only variant in which males are not more common than females) - morphology of R-S cell in mixed cellularity HL?
- classic R-S cell
- mixed cellularity HL is strongly associated with ?
- EBV
- rarest form of HL?
- lymphocyte depletion
- which age patient has a better prognosis when presenting with HL?
-
younger = better prognosis
older = more systemic involvement - what is the most prognostic variable of HL?
- tumor burden (stage)
- problem with long term survivors of HL treated with chemotherapy?
- increased risk of developing second cancers
-
in relation to acute leukemia:
1. what describes it?
2. what is the profile of normal hematopoietic stem cells? -
1. clonal expansion of transformed stem cells and failure of maturation
2. normal cells are suppressed -
1. ALL is a malignancy involving?
2. AML is a malignancy involving? -
1. transformation of lymphoid series
2. transformation of the myeloid series - describe the onset of acute leukemia?
- abrupt onset
-
for each of the following symptoms, explain the cause:
1. fatigue
2. fever
3. bleeding
4. bone pain -
1. fatigue is due to anemia
2. fever is due to neutropenia
3. bleeding is due to thrombocytopenia
4. bone pain is due to marrow expansion - what is the defining criteria (as far as lab finding go) for acute leukemia?
- 20% or greater blasts in the blood or bone marrow
- which leukemia accounts for 80% of childhood acute leukemias?
- ALL
- what age is the peak incidence of ALL?
- 4 yrs
- which sex is more commonly seen in ALL?
- males
- which type of ALL has a better prognosis: pre-B cell or pre-T cell ALL?
- pre-B cell ALL has a better prognosis
- which markers are seen in pre-B cell ALL?
-
CD19+
CD10+
sIg- - which markers are seen in pre-T cell ALL?
-
CD2+
CD5+
CD7+
sIg- - precursor T cell ALL closely resembles what lymphoma?
- lymphoblastic lymphoma
- TdT+ indicates what kind of cell?
-
very immature cell
(could be T or B cell) - what is the characteristic clinical feature of lymphoblastic lymphoma?
- prominent anterior mediastinal mass in 50-70% of pts.
- is lymphoblastic lymphoma common?
- yes (40% of all childhood lymphomas)
-
clinical situation:
19 yr. old male with huge mediastinal mass impinging on breathing? - lymphoblastic lymphoma
- what separates lymphoblastic lymphoma from pre-T cell ALL?
-
# of blasts in peripheral blood smear.
(lymphoblastic lymphoma may progress to pre-T cell ALL) -
in regards to cytogenetic abnormalities:
1. which one is associated with A GOOD PROGNOSIS?
2. which one is associated with a poorer prognosis? -
1. hyperdiploidy
2. translocations - which translocations are present in ALL? (3)
-
+(9;22)
+(4;11)
+(12;21) - prognosis for ALL?
-
90% acheive remission
2/3 considered cured -
as far as age goes:
which age is associated with a better prognosis?
how about a worse one? -
better prognosis: 2-10 yrs
worse pronosis: <1 yr, >10 yrs - AML affects primarily what age group?
- adults
- what is the morphology of the bone marrow seen in AML?
- Auer rods!
-
clinical scenario:
red dots on arms (petechiae)
kid complains of pain in leg
tired
50% blasts in peripheral blood
TdT+, CD10+, CD19+
what is the diagnosis? - precursor B cell leukemia
- what will a myeloperoxidase stain tell us?
-
it will show us cytoplasmic granules in AML
tells us we have a myeloid lineage, not a lymphoid lineage (VERY HELPFUL!) - which type of AML is treated differently and therefore "stands out" from all the others? (the one we need to know about?)
- M3 -> acute promyelocytic Leukemia
- what is acute promyelocytic leukemia characterized by as far as cell shape goes?
- characterized by a proliferation of abnormal promyelocytes
-
characteristic translocation seen in acute promyelocytic leukemia?
significance? -
+(15;17)
produces RARa-PML fusion protein - what are the abnormal promyelocyte cells seen acute promyelocytic cells called?
-
Faggot cells
(multiple Auer rods) - which stain are the abnormal promyelocytes positive for?
- myeloperoxidase stain
- what disorder is acute promyelocytic anemia associated with?
- DIC
- treatment for promyelocytic leukemia?
-
retinoic acid
(induces maturation of promyelocytes)
ALSO ADD CHEMOTHERAPY -
the following translocation is associated with?
+(9;22)
prognosis? -
AML-M1 (also CML)
(this is the Ph chromosome)
poor prognosis -
the following translocation is associated with?
+(8;21)
prognosis? -
AML-M2
more favoable prognosis -
the following translocation is associated with?
+(15;17) - acute promyelocytic anemia (AML-M3)
-
the following translocation is associated with?
Inv(16)
prognosis? -
subtype of M4 with increased eosinophils
longer median survival time than other types of AML - in contrast to AML: what is it called when the blast count in the bone marrow is less than 20%?
- myelodysplastic syndrome (MDS)
- MDS typically affects which age group?
-
older individuals
(over age 50-60) - In MDS: what does the peripheral blood and bone marrow show as far as cell count goes?
-
peripheral blood - pancytopenia
bone marrow - hypercellular - what are Pseudo-Pelger-Huet cells?
-
unilobed or bilobed neutrophils
(Harry Potter glasses) - what else in notable about the neutrophils seen in MDS?
-
they are agranular or hypogranular
(vs. hypergranular neurophils - seen in bacterial infx) - refractory anemia (RA) is characterized by?
-
ineffective erythropoiesis
predominately RBC disorder - what characterizes refractory anemia with ringed sideroblasts? (RARS)
- ringed sideroblasts (abnormal iron accumulation)
- what characterizes refractory cytopenia with multinlineage dysplasia? (RCMD)
- two or more blood cytopenias and dysplastic changes in two or more major lineages
- Auer rods are indicative of which type of MDS?
- RAEB (refractory anemia w/ excess blasts)
- what percentage of blasts are seen in RAEB?
- 5-9%
- what would the neutrophils look like in RAEB?
-
harry potter glasses (pseud-Pelger-Huet cell)
hypogranulation - which is the most aggressive of the MDS?
- RAEB
- what do cytopenias tell us about the prognosis of MDS?
- more pancytopenia - worse diagnosis
- RAEB effects which cell lineages?
-
ALL THREE
(pancytopenia with trilineage dyspoiesis) - what is the name of the new drug used to treat MDS?
- azacitidine
- what are the four chronic myeloproliferative disorders?
-
1. CML
2. Polycythemia vera
3. Primary myelofibrosis
4. Essential Thrombocytopenia - what can we do to easily rule out one of the chronic myeloproliferative disorders?
-
look for the Ph chromosome
(rule out CML) - why are all the chronic myeloproliferative disorders associated with splenomegaly?
- all have extramedullary hematopoiesis
- what is the "spent phase" seen in chronic myeloproliferative disorders?
-
marrow fibrosis
cytopenias - all chronic myeloproliferative disorders can progress to?
- acute leukemia
- what is the dominant cell line in CML?
- granulocytic precursors
- where does the Ph chromosome translocation lie?
-
+(9;22)
chr. 9 has ABL gene
chr. 22 has BCR gene
translocation results in BCR-ABL fusion - function of BCR-ABL fusion gene?
- directs synthesis of a fusion protein with tyrosine kinase activity
- peak incidence of age seen in CML?
- 30-40 yrs
- speed of onset of CML?
-
slow
initial symptoms are nonspecific - what two things cause the symptoms experienced in CML?
-
anemia
hypermetabolism
(fatigue, weakness, weight loss, anorexia) - what is result in the peripheral blood smear that is a tip-off telling us we have CML?
- elevated basophils
- what would the leukocyte count be in a pt with CML?
- > 100,000 cells per mm cubed
- what would the bone marrow look like in a CML patient?
-
hypercellular
granulocytic hyperlasia - what characteristic test can be used to distinguish CML from a leukemoid rxn?
-
LAP (leukocyte alkaline phosphatase)
CML - very very low LAP
leukemoid - high - what are the 3 clinical phases of CML?
-
1. Chronic
2. Accelerated
3. Blast - characteristics of the chronic phase?
-
relatively asymptomatic
hypercellular bone marrow
phase lasts 3-4 yrs - characteristics of the accelerated phase?
-
worsening anemia, thrombocytopenia
progressive myelofibrosis
increase in blasts (<20%) - characteristics of the blast crisis phase?
-
20-30% blasts
(50% enter the blast phase immediately following the chronic phase, skipping the accelerated phase) -
which drug induces remission in >90% of CML patients?
MOA? -
Gleevec
inhibits BCR-ABL kinase - which cell line dominates in polycythemia vera?
- erythroid precursors
- avg. age of onset of polycythemia vera?
- 60s
- what is the major clinical problem in p.vera?
-
increased blood volume and viscosity
see:
vascular stasis
thrombotic tendency
hemorrhage -
1. blood findings in P. vera?
2. bone marrow findings in P. vera? -
1. increased RBC count, Hgb, Hct.
2. hypercellular, increased erythroid precursors -
In P. vera:
1. LAP results?
2. presence of Ph. chromosome? -
1. increased
2. NO (Ph chr. absent) - P. vera patients have an increased risk of?
-
both hemorrhage and thrombosis
-hemorrhage b/c of abnormal platelet function and blood vessel distention - what is the treatment for P. vera?
-
phlebotomy
(decrease chance of thrombosis and hemorrhage) - what about P. vera and iron stores?
-
decreased iron stores
(secondary to chronic bleeding) - primary myelofibrosis involves the formation of abnormal megakaryocytic precursors that release what growth factors?
-
PDGF
TGF-B
(mitogenic for fibroblasts) - what is the hallmark of primary myelofibrosis?
- early progression to marrow fibrosis (similar to "spent phase" but earlier onset)
- in primary myelofibrosis: what happens as marrow fibrosis progresses?
- get extramedullary hematopoiesis (spleen. liver, lymph nodes)
- what are often the first 2 clinical presentations seen in primary myelofibrosis?
-
anemia
splenomegaly